ABBOTT PARK, Ill., Sept. 2, 2021
/PRNewswire/ -- Abbott (NYSE: ABT) announced today that
it has acquired Walk Vascular, LLC, a commercial-stage medical
device company with a minimally invasive mechanical aspiration
thrombectomy system designed to remove peripheral blood clots. Walk
Vascular's peripheral thrombectomy systems will be incorporated
into Abbott's existing endovascular product portfolio. Financial
terms were not disclosed.
"The acquisition of Walk Vascular fits well into our leading
vascular device offerings and further drives Abbott's ability to
provide one-of-a-kind endovascular therapy solutions to improve
patient care," said Julie Tyler,
senior vice president of Abbott's vascular business. "Walk
Vascular's technology provides physicians with tools to efficiently
remove dangerous clots from blood vessels to improve patient
care."
Walk Vascular's JETi Peripheral Thrombectomy System and
next-generation JETi AIO (All In One) Peripheral Thrombectomy
System are unique aspiration systems for the removal of
intravascular clots, known as thrombus, that can reduce blood flow
and lead to serious complications for patients. The innovative JETi
systems are designed to break-up and remove clots from the
peripheral vascular system while reducing the risk of dislodged
clots. The systems are backed by real-world clinical experiences,
and Walk is currently enrolling up to 250 patients in the United States and Europe in the JETi Registry.
Both the JETi Peripheral Thrombectomy Systems have received
510(k) clearance from the U.S. Food and Drug Administration (FDA)
for the aspiration and breaking up of soft emboli and thrombus from
the peripheral vasculature, as well as CE Mark in Europe and approvals in other countries.
About Abbott:
Abbott is a global healthcare leader
that helps people live more fully at all stages of life. Our
portfolio of life-changing technologies spans the spectrum of
healthcare, with leading businesses and products in diagnostics,
medical devices, nutritionals and branded generic medicines. Our
109,000 colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com, on LinkedIn
at www.linkedin.com/company/abbott-/, on Facebook
at www.facebook.com/Abbott and on Twitter
@AbbottNews.
View original
content:https://www.prnewswire.com/news-releases/abbott-expands-peripheral-vascular-offerings-with-acquisition-of-walk-vascular-llc-301368214.html
SOURCE Abbott